Aptatek
Princeton, US · 6 employees on LinkedIn · 1 known investors
Find your way into Aptatek
Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.
Founders & leadership
MS
Milan StojanovicCo-Founder, Scientific Advisor
TW
Tilla WorgallCo-Founder, Medical Advisor
MB
Michael Boyce-Jacino, PhDCEO, President, Board of Directors
Investors · 1
In the news
Frequently asked questions
- What does Aptatek do?
- Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.
- Who founded Aptatek?
- Aptatek was founded by Milan Stojanovic, Tilla Worgall.
- Who are Aptatek's investors?
- Aptatek's investors include Anzu Partners.
- Where is Aptatek headquartered?
- Aptatek is headquartered in Princeton, US.